碱性成纤维细胞生长因子壳聚糖微球的研制
Research and Development of Chitosan Microballoons of Alkaline Collagenoblast Growth Factor
-
摘要: 目的 探讨制备壳聚糖微球包裹碱性成纤维细胞生长因子 (bFGF)的方法。方法 采用Berthold的沉淀 /凝聚法制备壳聚糖微球 ,用此微球包裹bFGF ,对bFGF壳聚糖微球的大小、形态、含量和体外释药进行研究。结果 空白壳聚糖微球表面光滑 ,粒径范围 1.2~ 3.8μm。载药量约为 4 .6 8× 10 4U/mg ,包封率为 93.7%。体外释放试验显示 ,壳聚糖微球释放bFGF初期释药较快 ,尤其d 1有突释现象 (累计释药度约占 18.6 % ) ,随后bFGF释放速度逐渐变缓 ,d 10累计释放度约5 2 % ,d 2 0约 6 1.5 %。结论 bFGF壳聚糖微球具有较高的包封率和显著的缓释bFGF作用。
-
[1] 方华丰 周宜开.壳聚糖微球的研究进展[J].国外医药:合成药.生化药.制剂分册,1999,20(5):315-319,. [2] Nakao K, Itoh M, Tomita Y, et al. FGF - 2 potently induces both proliferation and DSP expression in collagen type I gel cultures of adult incisor immature pulp cells[J]. Biochem Biophys Res Commun,2004,325(3): 1052. [3] Diez del Corral R, Storey KG. Opposing FGF and retinoid pathways: a signalling switch that controls differentiation and patteming onset in the extending vertebrate body axis[J]. Bioessays,2004,26(8) :857. [4] Garcia- Molina JA, Vallespi - Miro G, Greco- Machado Y, et al. The role of fibroblast growth factor (FGF) and type beta transforming growth factor (TGF - beta 1 - beta 2 - beta 3)during rat craniofacial development[J]. Bull Group Int Rech Sci Stomatol Odontol, 2003,45 (2-3): 66. [5] Berthold A, Cremer K, Kreuter J. Prepatation and characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model foe anti - inflammatory drugs [J]. J Control Release, 1996, 39:17. [6] Varde NK, Pack DW. Microspheres for controlled release drug delivery[J]. Expert Opin Biol Ther, 2004,4(1): 35. [7] Kato Y, Onishi H, Machida Y. Application of chitin and chitosan derivatives in the pharmaceutical field [J]. Curr Pharm Biotechnol, 2003,4 (5): 303. [8] Sinha VR, Singla AK, Wadhawan S,et al. Chitosan microspheres as a potential carrier for drugs[J]. Int J Pharm, 2004,274(1 -2):1.
点击查看大图
计量
- 文章访问数: 940
- HTML全文浏览量: 20
- PDF下载量: 0
- 被引次数: 0